Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Fluvastatin MeSH Descriptor Data 2025


MeSH Heading
Fluvastatin
Tree Number(s)
D03.633.100.473.305
D10.251.450.300
Unique ID
D000077340
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077340
Scope Note
An indole-heptanoic acid derivative that inhibits HMG COA REDUCTASE and is used to treat HYPERCHOLESTEROLEMIA. In contrast to other statins, it does not appear to interact with other drugs that inhibit CYP3A4.
Entry Term(s)
7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate
Fluindostatin
Fluvastatin Sodium
Fluvastatin Sodium Salt
Lescol
XU 62-320
XU 62320
XU-62320
Registry Numbers
4L066368AS
0
PYF7O1FV7F
Related Numbers
93957-54-1
93957-55-2
PYF7O1FV7F
CAS Type 1 Name
6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (3R,5S,6E)-
Public MeSH Note
2019; FLUVASTATIN was indexed under FATTY ACIDS, MONOUNSATURED and INDOLES 1990-2018
History Note
2019 (1990)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/07/03
Fluvastatin Preferred
Lescol Narrower
XU 62-320 Narrower
Fluvastatin Sodium Narrower
7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate Narrower
page delivered in 0.164s